Major hedge funds are employing doctors, scientists, and analysts to gain insights into pharmaceutical stock movements. With recent shifts in the sector, firms like Balyasny and D.E. Shaw are recruiting medical experts to analyze drug trials and company growth prospects, aiming to stay ahead of market trends.